Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB-705498 in Rectal Hypersensitivity and IBS
NCT00461682Phase 2Terminated
- Sponsor
- GSK
- Start
- Jan 2007
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SB-705498 in rectal hypersensitivity (RH), irritable bowel syndrome (IBS), sponsored by GSK. Started Jan 2007; status: terminated.
02
Drugs
SB-705498
03
Conditions
rectal hypersensitivity (RH)irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00461682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00461682.